MANA Advisors’s Immunogen Inc IMGN Stock Holding History

MANA Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-26,336	Closed	-$169K	–	407
2017 Q4	$169K	Buy	+26,336	New	+$162K	0.07%	350

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MANA Advisors's IMGN Position: Q1 2018 in Review

MANA Advisors sold out of Immunogen Inc (IMGN) in Q1 2018, closing a stake of 26,336 shares — an estimated $169K sold.

MANA Advisors first reported a position in IMGN in Q4 2017 and held it in 1 quarter. The position peaked at $169K in Q4 2017. 204 funds tracked by Wall St. Rank hold IMGN as of Q1 2018.

MANA Advisors reported no remaining Immunogen Inc position as of Q1 2018 after selling out during the quarter.
MANA Advisors sold 26,336 Immunogen Inc shares in Q1 2018, an estimated $169K.
MANA Advisors first reported a position in Immunogen Inc in Q4 2017 and held it in 1 quarter.
MANA Advisors's Immunogen Inc position peaked at $169K in Q4 2017.
204 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2018.

Based on MANA Advisors's 13F filing for Q1 2018, filed 15 May 2018.